Rising costs of living, higher taxes, and higher inflation are the reasons why Americans have a negative perception of an allegedly strong economy.
The breakout above key resistance and the reversal of the VIX suggest that the recent correction is over. But there is a decent probability of another correction before November.
The big US stocks dominating markets and investors’ portfolios continue to thrive.
With turmoil in the Kremlin and no movement towards a ceasefire in the Middle East the market maintained a steady course on Monday, ahead of data dumps later in the week.
A tight trading range dominated Monday's S&P action, while participation remains high, breadth is pretty good, and a flush-out coming is debatable.
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. Over the past year, Elekta's share price fell about 9.4%.
SPX/VIX ratio leads the SPX and suggests new highs are coming for the SPX.